Milatuzumab [899796-83-9]

TargetMol Chemicals

Milatuzumab

9

899796-83-9

Antibody

Research Use Only

Milatuzumab

SDS-PAGE:95% SEC-HPLC:99.99%

Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.

3 years

-20°C

12352203